BIO-FD&C Co.,Ltd. (KOSDAQ: 251120)
South Korea
· Delayed Price · Currency is KRW
13,500
-250 (-1.82%)
Dec 20, 2024, 9:00 AM KST
BIO-FD&C Co.,Ltd. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
Operating Revenue | 16,067 | 15,592 | 15,855 | 11,972 | 8,640 | 8,476 | Upgrade
|
Other Revenue | -0 | -0 | - | -0 | - | -0 | Upgrade
|
Revenue | 16,067 | 15,592 | 15,855 | 11,972 | 8,640 | 8,476 | Upgrade
|
Revenue Growth (YoY) | 7.49% | -1.66% | 32.43% | 38.57% | 1.93% | 41.32% | Upgrade
|
Cost of Revenue | 4,946 | 4,563 | 4,859 | 4,895 | 3,032 | 2,864 | Upgrade
|
Gross Profit | 11,121 | 11,029 | 10,996 | 7,077 | 5,608 | 5,612 | Upgrade
|
Selling, General & Admin | 3,971 | 4,283 | 4,556 | 2,883 | 1,682 | 1,573 | Upgrade
|
Research & Development | 2,026 | 1,429 | 1,449 | 815.9 | 738.83 | 936.57 | Upgrade
|
Other Operating Expenses | - | - | - | 48.93 | 40.58 | 30.86 | Upgrade
|
Operating Expenses | 6,303 | 5,995 | 6,116 | 3,939 | 2,683 | 2,714 | Upgrade
|
Operating Income | 4,817 | 5,034 | 4,881 | 3,138 | 2,925 | 2,898 | Upgrade
|
Interest Expense | -69.71 | -127.82 | -108.93 | -62.29 | -69.67 | -73.08 | Upgrade
|
Interest & Investment Income | 1,270 | 1,098 | 564.04 | 30.95 | 56.22 | 47.38 | Upgrade
|
Currency Exchange Gain (Loss) | -50.16 | 2.09 | 130.71 | 133.49 | -90.4 | -8.32 | Upgrade
|
Other Non Operating Income (Expenses) | -19.86 | -25.13 | -19.47 | 44.7 | 57.97 | 108.76 | Upgrade
|
EBT Excluding Unusual Items | 5,948 | 5,981 | 5,447 | 3,284 | 2,879 | 2,973 | Upgrade
|
Gain (Loss) on Sale of Investments | 338.35 | 1,170 | -3.63 | - | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | 0.24 | 0.43 | - | 8.88 | 2.54 | 20.32 | Upgrade
|
Pretax Income | 6,286 | 7,152 | 5,443 | 3,293 | 2,881 | 2,993 | Upgrade
|
Income Tax Expense | 1,187 | 1,567 | 1,108 | 385.7 | 419.98 | 431.03 | Upgrade
|
Net Income | 5,099 | 5,585 | 4,335 | 2,908 | 2,461 | 2,562 | Upgrade
|
Net Income to Common | 5,099 | 5,585 | 4,335 | 2,908 | 2,461 | 2,562 | Upgrade
|
Net Income Growth | 7.91% | 28.83% | 49.10% | 18.12% | -3.92% | 550.06% | Upgrade
|
Shares Outstanding (Basic) | 9 | 9 | 9 | 7 | 7 | 7 | Upgrade
|
Shares Outstanding (Diluted) | 9 | 9 | 9 | 7 | 7 | 7 | Upgrade
|
Shares Change (YoY) | -3.60% | -3.21% | 19.10% | 0.39% | 0.11% | 15.81% | Upgrade
|
EPS (Basic) | 598.10 | 654.85 | 492.00 | 394.00 | 334.00 | 348.00 | Upgrade
|
EPS (Diluted) | 598.10 | 654.85 | 492.00 | 393.00 | 334.00 | 348.00 | Upgrade
|
EPS Growth | 11.94% | 33.10% | 25.19% | 17.66% | -4.02% | 461.29% | Upgrade
|
Free Cash Flow | 5,176 | 4,057 | 5,421 | -3,330 | 242.92 | 2,969 | Upgrade
|
Free Cash Flow Per Share | 607.16 | 475.71 | 615.19 | -450.12 | 32.96 | 403.35 | Upgrade
|
Gross Margin | 69.22% | 70.74% | 69.35% | 59.11% | 64.91% | 66.21% | Upgrade
|
Operating Margin | 29.98% | 32.29% | 30.78% | 26.21% | 33.85% | 34.19% | Upgrade
|
Profit Margin | 31.74% | 35.82% | 27.34% | 24.29% | 28.49% | 30.22% | Upgrade
|
Free Cash Flow Margin | 32.22% | 26.02% | 34.19% | -27.82% | 2.81% | 35.03% | Upgrade
|
EBITDA | 6,011 | 6,121 | 5,930 | 3,764 | 3,529 | 3,498 | Upgrade
|
EBITDA Margin | 37.41% | 39.26% | 37.40% | 31.44% | 40.84% | 41.27% | Upgrade
|
D&A For EBITDA | 1,194 | 1,087 | 1,049 | 626.04 | 603.95 | 600.58 | Upgrade
|
EBIT | 4,817 | 5,034 | 4,881 | 3,138 | 2,925 | 2,898 | Upgrade
|
EBIT Margin | 29.98% | 32.29% | 30.78% | 26.21% | 33.85% | 34.19% | Upgrade
|
Effective Tax Rate | 18.89% | 21.91% | 20.36% | 11.71% | 14.58% | 14.40% | Upgrade
|
Advertising Expenses | - | - | - | 11.56 | 70.13 | 180.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.